Aquestive Therapeutics Inc
NASDAQ:AQST
Cash Flow Statement
Cash Flow Statement
Aquestive Therapeutics Inc
Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||||||||||||||||||||
Net Income |
6
|
0
|
9
|
(9)
|
(3)
|
(34)
|
(57)
|
(61)
|
(80)
|
(64)
|
(68)
|
(66)
|
(68)
|
(50)
|
(48)
|
(56)
|
(54)
|
(64)
|
(62)
|
(71)
|
(69)
|
(73)
|
(71)
|
(54)
|
(33)
|
(23)
|
(12)
|
(8)
|
(29)
|
|
Depreciation & Amortization |
(0)
|
1
|
1
|
4
|
4
|
4
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
2
|
2
|
2
|
1
|
1
|
1
|
|
Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
27
|
29
|
30
|
31
|
6
|
7
|
7
|
7
|
7
|
7
|
7
|
6
|
6
|
7
|
7
|
6
|
7
|
5
|
4
|
4
|
2
|
2
|
3
|
0
|
|
Other Non-Cash Items |
1
|
1
|
2
|
3
|
2
|
31
|
37
|
37
|
40
|
12
|
14
|
14
|
14
|
14
|
9
|
11
|
15
|
19
|
23
|
36
|
33
|
31
|
27
|
10
|
8
|
4
|
2
|
5
|
10
|
|
Cash Interest Paid |
1
|
2
|
4
|
6
|
6
|
6
|
6
|
6
|
6
|
6
|
7
|
7
|
9
|
9
|
9
|
8
|
8
|
7
|
7
|
6
|
6
|
5
|
3
|
6
|
6
|
8
|
8
|
5
|
4
|
|
Change in Working Capital |
3
|
1
|
7
|
8
|
0
|
9
|
(0)
|
8
|
6
|
(0)
|
(1)
|
(11)
|
(5)
|
(16)
|
(7)
|
(4)
|
(10)
|
4
|
(3)
|
(2)
|
(0)
|
1
|
15
|
32
|
37
|
29
|
16
|
(5)
|
(8)
|
|
Cash from Operating Activities |
10
N/A
|
3
-66%
|
19
+482%
|
6
-69%
|
3
-54%
|
10
+252%
|
(18)
N/A
|
(13)
+26%
|
(31)
-142%
|
(49)
-56%
|
(52)
-7%
|
(60)
-15%
|
(56)
+7%
|
(49)
+13%
|
(43)
+13%
|
(45)
-7%
|
(46)
-1%
|
(38)
+18%
|
(38)
-2%
|
(33)
+14%
|
(33)
-1%
|
(38)
-14%
|
(26)
+31%
|
(10)
+63%
|
14
N/A
|
12
-10%
|
7
-42%
|
(6)
N/A
|
(26)
-301%
|
|
Investing Cash Flow | ||||||||||||||||||||||||||||||
Capital Expenditures |
1
|
0
|
(0)
|
(2)
|
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(3)
|
(3)
|
(2)
|
(3)
|
(1)
|
(1)
|
(1)
|
|
Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash from Investing Activities |
1
N/A
|
0
-71%
|
(0)
N/A
|
(2)
-3 350%
|
(2)
+19%
|
(1)
+16%
|
(1)
-1%
|
(2)
-28%
|
(2)
-7%
|
(1)
+27%
|
(1)
+25%
|
(1)
+38%
|
(0)
+38%
|
(0)
N/A
|
(0)
+12%
|
(1)
-44%
|
(0)
+6%
|
(1)
-18%
|
(1)
-7%
|
(1)
-47%
|
(1)
N/A
|
(1)
-53%
|
(3)
-118%
|
(3)
+17%
|
(2)
+4%
|
(3)
-6%
|
(1)
+61%
|
(1)
+1%
|
(1)
-3%
|
|
Financing Cash Flow | ||||||||||||||||||||||||||||||
Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
69
|
69
|
0
|
69
|
0
|
39
|
0
|
39
|
39
|
6
|
16
|
25
|
31
|
30
|
22
|
24
|
18
|
14
|
13
|
10
|
15
|
17
|
99
|
|
Net Issuance of Debt |
5
|
5
|
5
|
5
|
0
|
0
|
0
|
0
|
0
|
(1)
|
17
|
17
|
0
|
18
|
0
|
25
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(2)
|
(12)
|
(15)
|
(14)
|
(22)
|
(12)
|
|
Other |
0
|
0
|
0
|
(1)
|
(2)
|
(8)
|
(11)
|
(11)
|
(12)
|
(6)
|
(7)
|
(7)
|
(4)
|
(4)
|
(0)
|
(3)
|
(3)
|
(3)
|
(3)
|
(0)
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
9
|
8
|
|
Cash from Financing Activities |
5
N/A
|
5
N/A
|
5
-1%
|
4
-10%
|
(2)
N/A
|
(8)
-282%
|
58
N/A
|
58
+1%
|
57
-2%
|
62
+9%
|
10
-83%
|
50
+375%
|
52
+5%
|
53
+1%
|
39
-26%
|
28
-27%
|
38
+35%
|
47
+23%
|
53
+13%
|
30
-43%
|
22
-29%
|
23
+7%
|
17
-27%
|
12
-31%
|
1
-91%
|
(5)
N/A
|
0
N/A
|
4
+1 428%
|
95
+2 289%
|
|
Change in Cash | ||||||||||||||||||||||||||||||
Net Change in Cash |
16
N/A
|
9
-46%
|
24
+177%
|
8
-66%
|
(1)
N/A
|
0
N/A
|
39
+11 235%
|
43
+12%
|
23
-46%
|
12
-51%
|
(43)
N/A
|
(11)
+74%
|
(4)
+61%
|
3
N/A
|
(4)
N/A
|
(18)
-356%
|
(8)
+54%
|
9
N/A
|
14
+60%
|
(4)
N/A
|
(13)
-237%
|
(17)
-30%
|
(13)
+24%
|
(1)
+94%
|
12
N/A
|
5
-61%
|
6
+33%
|
(3)
N/A
|
68
N/A
|
|
Free Cash Flow | ||||||||||||||||||||||||||||||
Free Cash Flow |
11
N/A
|
4
-67%
|
19
+421%
|
4
-80%
|
1
-73%
|
8
+686%
|
(19)
N/A
|
(15)
+22%
|
(33)
-126%
|
(51)
-51%
|
(54)
-6%
|
(61)
-14%
|
(57)
+7%
|
(49)
+13%
|
(43)
+13%
|
(46)
-7%
|
(46)
-1%
|
(38)
+18%
|
(39)
-2%
|
(34)
+13%
|
(34)
-1%
|
(40)
-15%
|
(29)
+26%
|
(12)
+58%
|
11
N/A
|
10
-14%
|
6
-37%
|
(7)
N/A
|
(27)
-261%
|